Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
Status:
Completed
Trial end date:
2018-06-09
Target enrollment:
Participant gender:
Summary
The study is being done to find out whether combining two FDA approved drugs along with
radiation therapy for the treatment of high risk localized prostate cancer is safe and well
tolerated.